An amplified human sequence was isolated from a metastatic human lung carcinoma. A fragment of this sequence situated behind the lac promoter of pUC19 appeared to affect plasmid DNA supercoiling in certain E.coli strains. Subclones were constructed to identify the smallest region of the human insert that conferred the activity and a 369 bp fragment was identified, expression of which appeared to result in abnormal plasmid supercoiling. In order to study this phenotype, various constructs were introduced into the minicell-producing strain E. coli DS410 and an unexpected effect was observed. The bacteria, after normal early growth, clumped together in late log phase, leaving virtually clear medium. Other E.coli strains were also shown to be affected to a lesser degree. The sequence producing this effect was also mapped to the 369 bp fragment and a critical region of approximately 50 bp was identified using site-directed in vitro mutagenesis and fla/31 deletion analysis. The plasmid encoded product responsible for this phenotypic alteration did not appear to be a peptide and clumping was observed when the human DNA was expressed from several bacterial promoters. It would seem likely mat this sequence encodes a biologically active RNA which affects gene expression in the host cell.
INTRODUCTION
Studies on DNA isolated from human tumour samples have demonstrated that regions of DNA are sometimes over-represented in malignant cells when compared to the constitutional genotype. This phenomenon of DNA amplification may involve sequences linked to drug resistance (1) or cellular homologues of retroviral oncogene sequences (2, 3) .
Human c-Ki-ras is one of a family of related genes that have been implicated in malignant transformation. The gene has been found to be amplified in DNA extracted from a number of human tumours (4, 5) and in one case this was coupled with a mutationally-activated, single copy sequence (6) . In a previous study (7) we reported the isolation of a 7.5 kb fragment of human DNA, co-amplified more than 60 fold with c-Ki-ras, from a metastatic squamous cell lung tumour. The sequence was identified by hybridisation of the fragment with a 1.0 kb segment of DNA encoding the retroviral v-Ki-ras gene. It was shown to be located on chromosome 12p, as is c-Ki-ras, and to encode evolutionary-conserved sequence as determined by hybridisation to the DNA of a number of mammalian species. However, comparison of the restriction map with that of c-Ki-ras suggested that it was not part of this gene. A 1250 bp subclone of the original insert, in pUC19 (pK42), showed unusual effects in a number of E.coli strains. The plasmid DNA, after preparation by standard techniques, appeared to be present as a range of topoisomers, thus giving a ladderlike appearance on agarose gels. A second compatible plasmid introduced into a pK42 bearing host also showed the same supercoil heterogeneity suggesting a plasmid encoded product was responsible for the phenomenon. It was also demonstrated that inversion of the insert, with respect to the promoter, abolished the effect, further supporting this idea. The aim of this study was to characterise this fragment and determine the region necessary for activity. In the process, an unusual effect on cell growth was observed in some E.coli strains harbouring the recombinant plasmids.
MATERIALS AND METHODS
Bacterial Strains E.coli strains used were: JM109 (8), HB101 (9), DS410 (10), K12 (11), C600 (12) and BL21 (13) .
Cloning Vectors
The plasmid vectors used were: pUC18 and pUC19 (14) , pRTT5 and pRTT2T, supplied by Pharmacia LKB (15) and pcI857 (16) . M13 phage vectors used were mpl8 and mpl9 (14) . Plasmid DNA Isolation Large and small scale plasmid preparations were carried out using alkali lysis as described by Birnboim and Doly (1979) .
Growth of Bacterial Strains
Bacteria were grown in nutrient broth (Lab M, Bury) prepared as directed and sterilised in 500ml batches for 1 hour at 121 °C. Analysis of supercoil heterogeneity was carried out in E.coli JM109. A single colony of the plasmid bearing isolate was inoculated into 250ml of nutrient broth (containing ampicillin at 100 /tg ml-' and IPTG at 0.1 mM) and the culture grown for 16 hours at 240 rpm in an orbital shaker at 37 °C. Plasmid DNA was prepared as detailed and electrophoresed on a TAE (0.04 M Tris-acetate, 0.001 M EDTA, pH 7.9) 1 % agarose gel. The DNA was visualised by examination on an ultraviolet light box after staining for 30 mins in a 0.5 /tg ml" 1 solution of ethidium bromide. The assay for clumping was carried out in medium prepared as above in culture volumes varying from 1.5-500 ml. The bacteria were grown under a range of conditions but usually overnight at 37°C with shaking. Subcloning Procedure A number of subclones were produced by direct deletion of portions of sequence from the parental plasmid e.g. pK90. This construct was produced by digestion of pK42 with Accl and EcoRl. The ends were blunted using Klenow fragment polymerase and the larger fragment of the digest purified by electro-elution from an agarose gel (19) . The DNA was then ligated and transformed into E.coli JM109. A similar procedure was used if a fragment was to be excised from one vector and ligated into another and if ends were incompatible they were blunted. All supercoil heterogeneity analysis was carried out using the pUC19/18 vector systems.
DNA Sequencing
Plasmid DNA sequencing was carried out using a pUC Sequencing Kit (Boeringer Corporation (London) Ltd) as detailed by the manufacturer. M13 phage DNA sequencing was carried out using a kit supplied by Pharmacia LKB, again as directed by the manufacturer.
In vitro mutagenesis
In vitro mutagenesis was carried out using a kit supplied by Biorad Laboratories (Richmond) as directed by the manufacturer. The system was used to introduce mutations into ml3mpl8 phage bearing the 1250 bp insert of human DNA. After the mutation procedure the fragment was excised from the phage and re-cloned into pUC19. Oligonucleotides used (25 mers) were synthesised on a Dupont Coder 300 DNA synthesiser. BaBl Analysis 10 ng of circular plasmid DNA (pBEI) in a 50 /il reaction mix was cleaved with Accl to produce a linear fragment. An equal volume (50 /il) of BaBl buffer (24 mM CaCl 2 , 24 mM MgCl 2 , 0.4 M NaCl, 40 mM Tris-HCl, pH 8, 2 mM EDTA) was added to the tube followed by one unit of BaBl (BCL). 10 /d samples were removed at time intervals of 0, 20, 40, 60 and 120 seconds and rapidly added to 1 y\ of 0.2 M EGTA on ice to terminate the reaction. The samples were then electrophoresed and the linear bands for each reaction isolated. The DNA was precipitated with ethanol and resuspended in 31 /xl of distilled water. Ligase buffer, 1 unit of T4 DNA ligase (Bethesda Research Ltd) and 1 unit of Klenow fragment polymerase (Northumbria Biologicals Ltd) were then added. The ligation reactions were incubated overnight and l A of each mix was used to transform E.coli DS410. Clones were assayed for clumping activity as described and those found to be informative were sequenced.
RESULTS
In order to investigate the effect of the putative plasmid product on supercoiling, the recombinant plasmid pK42 (7) was introduced into the minicell producing strain E. coli DS410 (10) . A very unusual effect was noted in that the bacteria, after normal initial growth, clumped dramatically in late log phase leaving a virtually clear medium containing large bacterial masses. As with the supercoil abnormalities seen in E.coli JM109 (but not DS410), this effect was orientation specific since the pUC18 construct carrying the 1250 bp insert, reversed with respect to the lac promoter (pK42R), permitted normal growth of DS410. The clumping could be prevented by the incorporation of glucose (0.2 % w/v) in the growth medium whereas galactose at the same concentration had little effect.
A number of subclones of pK42 were constructed to localise the sequence responsible for the growth and supercoil effects. The fragments were clones into various sites in the pUC19 poly-linker to create the plasmids indicated ( Figure 1 , Table 1 ). The smallest construct encoding clumping activity in DS410 ( Figure 2 ) was a 369 bp RsaVAccl fragment of pK42 cloned into the Small EcdRi sites of pUC19 (pK115). All constructs containing this region, in the correct orientation, caused bacterial adhesion to approximately the same degree. Supercoil heterogeneity was also observed in E.coli JM109 preparations of pK115 but to a much reduced level when compared with pK42. However, it was interesting to note that some of the larger constructs did not induce the supercoil heterogeneity in this strain. The most effective plasmids were pK42 and pK90, suggesting that the terminal 300 base pairs were not important in this respect. pK70 and pK220 were almost as efficient but pK230 was only very weakly active and pKlOl was inactive. The clone pK49, generated by a deletion of the 600 bp Accl fragment of pK42, and pK52 allowed normal growth of DS410 and produced normally supercoiled plasmid in JM109 as judged by agarose gel electrophoresis. It was therefore concluded that the product responsible for the unusual phenotype was encoded by the 369 bp RsaVAccl fragment but that upstream sequences may enhance the activity with respect to the apparent unwinding of the plasmid DNA.
The sequence of the pKl 15 insert was determined in both directions using a combination of plasmid and phage dideoxy sequencing (Figure 3 ). It was assumed at this time that the plasmid encoded a peptide responsible for the biological effect. An open reading frame of 245 bp was identified and it was decided to sequentially inactivate the ATG codons of Clones Generated from pK42
Insert cloning sites
Plasmid cloning sites Table 1 . If the enzymes used generated incompatible staggered ends these were blunted before ligation using Klenow fragment polymerase. These ends are denoted by a (b) in the table. pUCI9 was used for all clones apart from pK42R where pUC18 was the vector. ' The re-created Hindm site of pAXl was cut, filled and religated to create a translational stop codon in pAXSl.
• Denotes ATG codons in the long open reading frame of the 369 bp RsaVAccl fragment.
along this sequence to try to destroy both activities. The inactivation was carried out by in vitro mutagenesis and new restriction sites were created in the process. This allowed the generation of new subclones to further localise the active sequence. ATG codons at positions 54, 75, 148 (out of frame), 189 and 219/222 bp were altered with no effect on either activity. However, one subclone (pAXl) was found to induce a much reduced clumping activity in DS410. In this subclone the ATG at position 75 of the 369 bp RsaVAccl fragment was altered to GAG thereby creating a new Xhol site. The 580 bp CAGATGATG was changed to CAGATCTYG to create a new BgUl site. The 1250 bp HindSUEcoYtl fragment was re-inserted into the polylinker of pUC19 to create the plasmid pK510. As stated, this mutation had no effect on die clumping or unwinding activity of the construct but it enabled the construction of two further subclones (pBEI and pHBI). pHBI was inactive and did not cause supercoil abnormalities or bacterial aggregation. pBEI, however, conferred the full clumping phenotype but appeared normally supercoiled in JM109. This plasmid was further modified by digestion with Accl and EcoRl to release a 300 bp fragment. The molecule was then re-circularised after blunting of the staggered ends to produce a derivative carrying the BglWAccl fragment of pK510 cloned into the HindlWEcoKl sites of pUC19 (pBEDI). This construct also had full clumping activity in DS410 and the active sequence therefore appeared to reside within the 150 bp between the new BglR site and the Accl site of the original fragment. It is worth noting that the fusion of the blunted BgCU site with the blunted HinaTH site places a translational stop codon (AAGC7t/,4TCT) in frame with the lac Z initiation codon. This suggests that the active product is not a fusion peptide initiated from the lac Z ATG. In order to further define the active region, Bo/31 deletion analysis was carried out. Four deletion mutants with full activity, three with partial activity and three with no detectable activity were sequenced (Figure 4) . This procedure identified a small active region of approximately 50 bp that appeared to contain a DNA sequence essential for clumping activity. However, as pBEI does not show the supercoil heterogeneity effect it is possible that sequences upstream of this region but within the 369 bp RsaUAccl fragment are important for this function. The Styl site within the 50 bp active sequence encoded by pBEDI was cut and the staggered ends filled with Klenow polymerase. After re-ligation of the now blunt ends the plasmid was transformed into DS410. The resulting construct, containing an additional 4 bp, was not capable of inducing clumping, thus confirming that this region contains sequences necessary to induce the phenotype. Reconstruction studies (into a pK90 vector) also suggested that this particular mutation greatly reduced the ability of the putative active region product to influence the DNA supercoiling of a JM109 host (data not shown).
The constructs pK42 and pK115 were tested for the induction of bacterial clumping in a number of E.coli K strains. DS410 was clumped most effectively but C600 and K12 isolates showed a lower but marked degree of aggregation. When the plasmids were introduced into JM109 it was possible to see clumps of bacteria using a low power microscope in the pKl 15 bearing isolate but not in the pK42 or control (pUC19) cultures. No clumping was seen if either plasmid was introduced into HB101. There were no obvious known differences in genotype that could account for the different levels of aggregation induced in the various strains. A number of constructs were introduced into an E.coli B derivative BL21. In this strain clumping was seen with pK42, pK90, pK70 and pK220 but no other constructs. This would suggest that an upstream region present in addition to the 369 bp RsaUAccl fragment is necessary for activity in this strain.
The 1250 bp HinaTWEcoRl fragment of pK42 was inserted into the HindWEcoRl sites of pRIT5 and pRIT2T (15) . Expression of the human DNA fragment in these two new constructs (pOPl and pOP7) was thereby placed under the control of the respective Staphylococcal protein A and XP R promoters. Both new constructs induced clumping in DS410 whereas the original vectors allowed normal growth. A compatible plasmid bearing a temperature sensitive X repressor pcI857 (16) was introduced into a pOP7 bearing DS410 host. This down regulated the X promoter of pOP7 at 28°C but allowed normal expression at 42°C. Clumping was induced in this isolate when the host was grown at 42°C but not at 28°C. DS410 bearing pOP7 showed marked clumping at both temperatures. A surprising finding was that the incorporation of glucose (0.2% w/v) in the growth medium totally prevented bacterial aggregation in DS410 cultures bearing either pOPl or pOP7.
DISCUSSION
The results presented describe the detailed characterisation of a novel sequence, amplified in a human tumour and possessing biological activity in E.coli. Attention was initially focused on the pK42 insert because of the effect on plasmid supercoiling created by expression of the sequence. During this study an unusual property of the recombinant plasmid, that of inducing bacterial aggregation, was noted. It appeared that the active sequence for both these effects lay within the 369 bp RsaUAccl fragment. However, with respect to the supercoil heterogeneity it would appear that a region upstream of this fragment is important in the production of this effect. Evidence for this comes from the fact that the clones showing the maximum supercoil heterogeneity are pK42 and pK90. As shorter clones are used the apparent efficiency drops until the AccVAccl fragment insert in pUC19(pK101) appears to show normal supercoiling although the shorter clone pK115 shows the abnormal response. The fact that pK220 induces a near maximal effect on supercoil heterogeneity suggests that the sequence between HindUl and the first Ncol site is important in this respect. However, only clones carrying the 369 bp RsaUAccl fragment show either activity and this suggests that the active region is located within this fragment. Further evidence comes from the pHBl construct which has neither activity despite carrying the first 800 bp of the 1250 bp insert downstream of the lac promoter of pUC19. This suggests that the sequence between nucleotides 218 and 369 of the RsaUAccl fragment are crucial for both activities. The active region for clumping has been further localised to nucleotides 218-267 of this sequence. It seems highly likely that the product of this sequence is responsible for both effects in the bacterial cells. However, it is very difficult to conceive that a peptide, producing the biological effects observed, is encoded by this region. If this were the case it would have to be very small and initiated at a codon other than ATG, internal to the cloned fragment. The most likely explanation of the phenomenon is that the RNA molecule transcribed from the lac promoter is the biologically active agent.
Evidence from several constructs would suggest that translation of the RNA strand in at least one reading frame interferes with the clumping phenomenon. It is possible that translation interferes with the structure and hence activity of the putative RNA molecule.
Catalytically active RNA molecules have been described in a number of systems (for review see 20) , for example, the RNase P complex where the active site of the enzyme is an RNA sequence (21, 22) . It is possible that the human sequence is producing a catalytically active RNA within the bacterial cell. An alternative explanation would be that the RNA sequence is binding an E.coli factor and is thus affecting gene expression within the cell indirectly. Neither the clumping effect nor the supercoil effect is limited to any one strain. However, the magnitude of the effect does vary between strains. This is seen most clearly in the ability of the constructs to clump bacteria. In the E. coli K strains tested, the most active plasmid appears to be pKl 15 but this is not the case in the E.coli B strain where, in addition, an upstream region is necessary to produce clumping. It would seem likely that this is the same sequence linked to the supercoil heterogeneity production in the larger constructs.
The mode of action of the putative RNA molecule encoded by the active region is unknown. However, it is interesting to note that changes in the level of DNA supercoiling can lead to changes in gene expression in bacterial systems (23) . It is therefore tempting to speculate that the plasmid product affects the control of this system thereby causing the activation or inactivation of certain gene(s) which may lead to phenotypic effects, for example, bacterial aggregation. However, the amount of supercoil heterogeneity (as determined by standard gel electrophoresis) for some constructs does not correlate well with the observed clumping, the most striking example is pKlOl which shows no heterogeneity but causes a high degree of aggregation comparable to pK42. In addition, DS410 would appear to show normal levels of plasmid supercoiling with all constructs but is the host showing maximum aggregation.
An alternative and perhaps more likely explanation for the two effects is that the plasmid product is affecting control of gene expression at a high level and this leads indirectiy to the two effects observed in the bacteria as expression is changed either selectively or generally in the host cell. It is interesting to note that both effects were prevented if glucose was incorporated in the culture medium, regardless of the promoter system used. There are several possible explanations for this result, the most obvious being that glucose directly prevents the adhesion of the cells by interfering with a cell surface component but this does not explain the lack of supercoil heterogeneity. An alternative explanation is that the effects observed are mediated in a cyclic AMP dependent fashion with high levels of glucose in the medium lowering the internal level of cAMP. In this case the insert encoded plasmid product could activate a gene or several genes that require high levels of cAMP for transcription to take place.
Attempts are now being made to introduce this sequence into human cells in vectors which allow transcription in a sense or anti-sense direction. If the active product is in fact an RNA molecule that interacts in some fundamental way with cellular macromolecules, for example with DNA, it is hoped that a biological effect will be observed. It is known that the pK42 insert sequence is transcribed at very low levels in human cells and a short incomplete cDNA clone homologous to a sequence immediately downstream of the active region has been isolated (data not shown). Attempts are now being made to isolate longer cDNA clones. In addition it may be useful to develop the clumping effect as a method of removing bacterial cells from suspension.
